D-Sight (Biotechnology) Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.37M

  • Investors
  • 2

D-Sight (Biotechnology) General Information

Description

Operator of a biotech company intended to develop innovative neuroprotective treatments that prevent vision loss from retinal neurodegenerative diseases. The company offers neuroprotective eye drops designed to treat retinal diseases at their earliest stages, enabling customers to preserve vision through a non-invasive approach that targets the underlying neurodegeneration.

Contact Information

Website
www.dsight.es
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Passeig de la Vall d'Hebron 119-129 Edifici Mediterrània
  • 08035 Barcelona
  • Spain
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Passeig de la Vall d'Hebron 119-129 Edifici Mediterrània
  • 08035 Barcelona
  • Spain

D-Sight (Biotechnology) Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

D-Sight (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 26-Feb-2026 $2.37M Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
1. Spin-Off 01-Jan-2023 Completed Generating Revenue
To view D-Sight (Biotechnology)’s complete valuation and funding history, request access »

D-Sight (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

D-Sight (Biotechnology) Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clave (Pamplona) Venture Capital Minority
Grit Female Accelerator Accelerator/Incubator
To view D-Sight (Biotechnology)’s complete investors history, request access »

D-Sight (Biotechnology) FAQs

  • When was D-Sight (Biotechnology) founded?

    D-Sight (Biotechnology) was founded in 2023.

  • Where is D-Sight (Biotechnology) headquartered?

    D-Sight (Biotechnology) is headquartered in Barcelona, Spain.

  • What is the size of D-Sight (Biotechnology)?

    D-Sight (Biotechnology) has 3 total employees.

  • What industry is D-Sight (Biotechnology) in?

    D-Sight (Biotechnology)’s primary industry is Biotechnology.

  • Is D-Sight (Biotechnology) a private or public company?

    D-Sight (Biotechnology) is a Private company.

  • What is D-Sight (Biotechnology)’s current revenue?

    The current revenue for D-Sight (Biotechnology) is .

  • How much funding has D-Sight (Biotechnology) raised over time?

    D-Sight (Biotechnology) has raised $2.37M.

  • Who are D-Sight (Biotechnology)’s investors?

    Clave (Pamplona) and Grit Female Accelerator have invested in D-Sight (Biotechnology).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process